PET supports this call to improve access to NHS genetic testing for cancer susceptibility, so that people do not miss out on monitoring, screening or preventive treatment that could help them. At the same time, we echo the accompanying caution that care must be taken to weigh the benefits of more testing against possible harms, such as the anxiety and distress that can result from ambiguous findings. Science in this area moves fast, and it is important that NHS guidelines keep up.